Ioana Hone | Head of IR |
Brian Culley | CEO and Interim CFO |
Gary Hogge | SVP, Clinical and Medical Affairs |
William Wood | B. Riley Securities |
Rick Miller | Cantor Fitzgerald |
Michael Okunewitch | Maxim Group |
Welcome to the Lineage Cell Therapeutics Third Quarter 2022 Conference Call. At this time, all participants are in a listen-only mode. An audio webcast of this call is available on the Investors section of Lineage's website at www.lineagecell.com. This call is subject to copyright and is property of Lineage. Recordings, reproductions, or transmissions of this call without the express written consent of Lineage are strictly prohibited.